Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Yang Yu(Obstetrics and Gynecology Hospital of Fudan University), Ryan J. Watts(Denali Therapeutics (United States)), Nga Bien‐Ly(Alector (United States)), James A. Ernst, William J. Meilandt, Jessica A. Couch(Sunesis (United States)), Wilman Luk(Genentech), Daniela Bumbaca(Genentech), Kwame Hoyte, Kapil Gadkar(Sea Turtle Conservancy), Kristin R. Wildsmith(Eisai (United States)), Janice Maloney, Mark S. Dennis(Denali Therapeutics (United States)), Yanmei Lu, Yin Zhang(Sun Yat-sen University), Raymond K. Tong, Maria Hersom(University of Copenhagen), Christine Tan, Jasvinder K. Atwal, Kimberly Scearce‐Levie
Cited by 373
Related Papers
Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease
|Neuron|2007|1.7k
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
|Nature Biotechnology|2008|1.4k
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
|Journal of Biological Chemistry|2002|496
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
|The Journal of Experimental Medicine|2014|353